S&P 500   4,274.51
DOW   33,550.27
QQQ   355.04
Pain for Gain: 2 Stocks Whose CEOs Left Without a Clue
U.S. drive to onshore battery supply chains could create big winners in lithium (Ad)
The Odds Are High Costco Will Declare a Special Dividend Soon 
Stock market today: Global shares mostly fall over China worries
Would Buffett Approve of This Growth Strategy? (Ad)
How You Can Reverse Engineer Michael Burry's Latest Buy
Target Will Close 9 Stores Across 4 States Due to Ongoing Crime That's 'Threatening the Safety' of Customers and Employees
Would Buffett Approve of This Growth Strategy? (Ad)
Video: Jack in the Box Employee Shoots at Customer Over Alleged Missing Curly Fries, Family Files Lawsuit
3 Mid-Cap Momentum Plays to Ride Into Q4
S&P 500   4,274.51
DOW   33,550.27
QQQ   355.04
Pain for Gain: 2 Stocks Whose CEOs Left Without a Clue
U.S. drive to onshore battery supply chains could create big winners in lithium (Ad)
The Odds Are High Costco Will Declare a Special Dividend Soon 
Stock market today: Global shares mostly fall over China worries
Would Buffett Approve of This Growth Strategy? (Ad)
How You Can Reverse Engineer Michael Burry's Latest Buy
Target Will Close 9 Stores Across 4 States Due to Ongoing Crime That's 'Threatening the Safety' of Customers and Employees
Would Buffett Approve of This Growth Strategy? (Ad)
Video: Jack in the Box Employee Shoots at Customer Over Alleged Missing Curly Fries, Family Files Lawsuit
3 Mid-Cap Momentum Plays to Ride Into Q4
S&P 500   4,274.51
DOW   33,550.27
QQQ   355.04
Pain for Gain: 2 Stocks Whose CEOs Left Without a Clue
U.S. drive to onshore battery supply chains could create big winners in lithium (Ad)
The Odds Are High Costco Will Declare a Special Dividend Soon 
Stock market today: Global shares mostly fall over China worries
Would Buffett Approve of This Growth Strategy? (Ad)
How You Can Reverse Engineer Michael Burry's Latest Buy
Target Will Close 9 Stores Across 4 States Due to Ongoing Crime That's 'Threatening the Safety' of Customers and Employees
Would Buffett Approve of This Growth Strategy? (Ad)
Video: Jack in the Box Employee Shoots at Customer Over Alleged Missing Curly Fries, Family Files Lawsuit
3 Mid-Cap Momentum Plays to Ride Into Q4
S&P 500   4,274.51
DOW   33,550.27
QQQ   355.04
Pain for Gain: 2 Stocks Whose CEOs Left Without a Clue
U.S. drive to onshore battery supply chains could create big winners in lithium (Ad)
The Odds Are High Costco Will Declare a Special Dividend Soon 
Stock market today: Global shares mostly fall over China worries
Would Buffett Approve of This Growth Strategy? (Ad)
How You Can Reverse Engineer Michael Burry's Latest Buy
Target Will Close 9 Stores Across 4 States Due to Ongoing Crime That's 'Threatening the Safety' of Customers and Employees
Would Buffett Approve of This Growth Strategy? (Ad)
Video: Jack in the Box Employee Shoots at Customer Over Alleged Missing Curly Fries, Family Files Lawsuit
3 Mid-Cap Momentum Plays to Ride Into Q4
NASDAQ:BGXX

Bright Green (BGXX) Stock Forecast, Price & News

$0.38
+0.03 (+8.52%)
(As of 09/27/2023 ET)
Compare
Today's Range
$0.35
$0.40
50-Day Range
$0.34
$0.82
52-Week Range
$0.33
$1.88
Volume
849,039 shs
Average Volume
1.89 million shs
Market Capitalization
$68.61 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A

Bright Green MarketRank™ Forecast

Analyst Rating
N/A
Upside/​Downside
N/A
Short Interest
Healthy
4.07% of Float Sold Short
Dividend Strength
N/A
Sustainability
N/A
News Sentiment
0.19mentions of Bright Green in the last 14 days
Based on 2 Articles This Week
Insider Trading
Selling Shares
$117,500 Sold Last Quarter
Proj. Earnings Growth
N/A

Overall MarketRank

MarketRank is calculated as an average of available category scores, with extra weight given to analysis and valuation.

1.38 out of 5 stars

Medical Sector

926th out of 976 stocks

Medicinals & Botanicals Industry

10th out of 12 stocks


BGXX stock logo

About Bright Green (NASDAQ:BGXX) Stock

Bright Green Corporation is a vertically integrated cannabis company and multi-state operator in the US and internationally. The company was incorporated in 2019 and is based in Fort Lauderdale, Florida. Bright Green Corporation went public via a direct listing on the NASDAQ in May 2022.

Bright Green Corporation grows, manufactures, and sells cannabis and cannabis-related products legally under federal and state laws for research, pharmaceutical applications, and export. By the end of 2022, the company had 4 patents under enforcement and 17 pending with more expected each year.

Unlike other cannabis companies in the budding industry, Bright Green Corporation has a contract with the US Drug Enforcement Administration that allows it to produce cannabis and cannabis products legally at both the state and federal levels. The contract permits Bright Green Corporation to supply approved researchers with THC-bearing cannabis for the purposes of medical research. The contract also permits the company to make and market therapies and treatments that are derived from said research and to export cannabis and cannabis products internationally.

The true value of the agreement with the DEA is that Bright Green Corporation can produce and market cannabis to any pharmaceutical or research company with a Schedule 1 license. This means big pharmaceutical companies can get ahead of the curve and begin their work on cannabis and cannabinoid medicines and therapies before cannabis is legalized at the Federal level.

The business is built around a state-of-the-art production facility that allows 24/7/365 production of cannabis and derivative products. The 22-acre facility is fully automated to ensure consistent quality across all product lines and processes. The facility remodel was completed in mid-2022 with production beginning later that year. Two more 55-acre facilities are in the works and, once completed, will make the company the largest federally legal producer of cannabis for the research market.

Some of the benefits of the Bright Green Corporation process and product include consistent tissue culture and superior genetics which is a must for research quality cannabis. Consistent tissue culture is ensured by using small clippings to grow fully mature clones of the original plant in highly controlled environments versus the risk of genetic contamination or mutations via seeds. Superior genetics means Bright Green Corporation’s core strains were bred to target qualities including cannabinoid homogenization (consistent distribution throughout the plant), mildew resistance, and plant architecture as well as high levels of cannabinoids.

The Bright Green Process also means increased yields, full-year/year-round cultivation, and improved profitability for commercialized products. The company operates under full Good Agricultural and Collection Practices guidelines and is compliant with the FDA’s Good Manufacturing Process mandate as well as with the USDA for full operations within the US.

 

BGXX Price History

BGXX Stock News Headlines

Windfall profits possible with this under-the-radar lithium stock.
Investor Find Lithium Gold and Crush the Bear Market with 32k Metric Tons
Windfall profits possible with this under-the-radar lithium stock.
Investor Find Lithium Gold and Crush the Bear Market with 32k Metric Tons
Bright Green Operational Update
Premarket Action Heating Up For This Pharma Stock
Bright Green GAAP EPS of -$0.02
See More Headlines
Receive BGXX Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Bright Green and its competitors with MarketBeat's FREE daily newsletter.

BGXX Company Calendar

Last Earnings
8/16/2023
Today
9/28/2023
Next Earnings (Estimated)
11/13/2023
Fiscal Year End
12/31/2023

Industry, Sector and Symbol

Industry
Medicinals & botanicals
Sub-Industry
N/A
Sector
Medical
Current Symbol
NASDAQ:BGXX
Fax
N/A
Employees
23
Year Founded
N/A

Profitability

Net Income
$-27,660,000.00
Pretax Margin
N/A

Debt

Sales & Book Value

Annual Sales
N/A
Book Value
$0.07 per share

Miscellaneous

Free Float
78,387,000
Market Cap
$68.61 million
Optionable
Not Optionable
Beta
0.63
20 Stocks to Sell Now Cover

MarketBeat has just released its list of 20 stocks that Wall Street analysts hate. These companies may appear to have good fundamentals, but top analysts smell something seriously rotten. Are any of these companies lurking around your portfolio? Find out by clicking the link below.

Get This Free Report

Key Executives

  • Mr. Saleem Elmasri CPA (Age 37)
    Chief Financial Officer
    Comp: $2.26M
  • Mr. Seamus McAuley (Age 46)
    Chief Exec. Officer













BGXX Stock - Frequently Asked Questions

How have BGXX shares performed in 2023?

Bright Green's stock was trading at $0.4695 at the start of the year. Since then, BGXX shares have decreased by 18.6% and is now trading at $0.3820.
View the best growth stocks for 2023 here
.

When is Bright Green's next earnings date?

The company is scheduled to release its next quarterly earnings announcement on Monday, November 13th 2023.
View our BGXX earnings forecast
.

How were Bright Green's earnings last quarter?

Bright Green Co. (NASDAQ:BGXX) issued its earnings results on Wednesday, August, 16th. The company reported ($0.02) earnings per share (EPS) for the quarter.

What ETF holds Bright Green's stock ?

ETFMG U.S. Alternative Harvest ETF holds 2,406,355 shares of BGXX stock, representing 1.46% of its portfolio.

When did Bright Green IPO?

(BGXX) raised $1.3 billion in an IPO on Tuesday, May 17th 2022. The company issued 158,300,000 shares at a price of $8.00 per share. EF Hutton served as the underwriter for the IPO.

What is Bright Green's stock symbol?

Bright Green trades on the NASDAQ under the ticker symbol "BGXX."

Who are Bright Green's major shareholders?

Bright Green's stock is owned by a variety of retail and institutional investors. Top institutional investors include BlackRock Inc. (1.90%), Geode Capital Management LLC (0.71%), State Street Corp (0.50%), Northern Trust Corp (0.30%), Bank of New York Mellon Corp (0.17%) and Charles Schwab Investment Management Inc. (0.09%).
View institutional ownership trends
.

How do I buy shares of Bright Green?

Shares of BGXX stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is Bright Green's stock price today?

One share of BGXX stock can currently be purchased for approximately $0.38.

How much money does Bright Green make?

Bright Green (NASDAQ:BGXX) has a market capitalization of $68.61 million. The company earns $-27,660,000.00 in net income (profit) each year or ($0.09) on an earnings per share basis.

How can I contact Bright Green?

The official website for the company is www.brightgreen.us. The company can be reached via phone at 833-658-1799 or via email at brightgreenir@edelman.com.

This page (NASDAQ:BGXX) was last updated on 9/28/2023 by MarketBeat.com Staff

My Account -